Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in
glabellar rhytides (frown lines) using a new treatment satisfaction measure.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA